Open access · CC-BY
via OpenAlex
Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis
Journal of Personalized Medicine · 2020 · ▲ 271 citations
Abstract
Obesity is a major risk factor for developing gallstone disease (GSD). Previous studies have shown that obesity is associated with an elevated Firmicutes/Bacteroidetes ratio in the gut microbiota. These findings suggest that the development of GSD may be related to gut dysbiosis. This review presents and summarizes the recent findings of studies on the gut microbiota in patients with GSD. Most of the studies on the gut microbiota in patients with GSD have shown a significant increase in the phyla Firmicutes (Lactobacillaceae family, genera Clostridium, Ruminococcus, Veillonella, Blautia, Dorea, Anaerostipes, and Oscillospira), Actinobacteria (Bifidobacterium genus), Proteobacteria, Bacteroidetes (genera Bacteroides, Prevotella, and Fusobacterium) and a significant decrease in the phyla Bacteroidetes (family Muribaculaceae, and genera Bacteroides, Prevotella, Alistipes, Paludibacter, Barnesiella), Firmicutes (genera Faecalibacterium, Eubacterium, Lachnospira, and Roseburia), Actinobacteria (Bifidobacterium genus), and Proteobacteria (Desulfovibrio genus). The influence of GSD on microbial diversity is not clear. Some studies report that GSD reduces microbial diversity in the bile, whereas others suggest the increase in microbial diversity in the bile of patients with GSD. The phyla Proteobacteria (especially family Enterobacteriaceae) and Firmicutes (Enterococcus genus) are most commonly detected in the bile of patients with GSD. On the other hand, the composition of bile microbiota in patients with GSD shows considerable inter-individual variability. The impact of GSD on the Firmicutes/Bacteroidetes ratio is unclear and reports are contradictory. For this reason, it should be stated that the results of reviewed studies do not allow for drawing unequivocal conclusions regarding the relationship between GSD and the Firmicutes/Bacteroidetes ratio in the microbiota.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/jpm11010013
- Canonical
- link ↗
- Fetched
- 2026-06-14 MST
Cite this
APA
Григорьева, �.�. (2020). Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis. <em>Journal of Personalized Medicine</em>. https://doi.org/10.3390/jpm11010013
Vancouver
Григорьева ��. Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis. Journal of Personalized Medicine. 2020. doi:10.3390/jpm11010013.
BibTeX
@article{2020Gallst,
title = {Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis},
author = {И. Н. Григорьева},
journal = {Journal of Personalized Medicine},
year = {2020},
doi = {10.3390/jpm11010013},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Psychiatry 2019
Open access · CC-BY
Systematic Review of Gut Microbiota and Major Depression
Journal of the American Heart Association 2021
Open access · CC-BY
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
Advances in Therapy 2020
Open access · CC-BY
Current Perspectives on Gut Microbiome Dysbiosis and Depression
npj Parkinson s Disease 2021
Open access · CC-BY
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
Nutrients 2020
Open access · CC-BY
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Gut Pathogens 2016
Open access · CC-BY